Coronary disease & ACS

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment

HeartPublished Diagnostic performance analysis of troponin assays

Authors' conclusion

The diagnostic performance of an unadjusted troponin cut-off for AMI falls with worsening renal function. We propose consideration of eGFR specific cut-offs to support more effective triage and early management of suspected AMI in patients with renal impairment.

Study context

Population
Patients with troponin measurement at four acute tertiary care hospitals in London, UK, between 2010 and 2017patients included
Participants
221,175 patients
Comparison
Troponin for diagnosing acute myocardial infarction (AMI), stratified by estimated glomerular filtration rate (eGFR)
Outcome
Patient characteristics
Methodological detailsfour acute tertiary care hospitals in London, UK, 2010–2017
  • Four acute tertiary care hospitals in London, UK
  • 2010–2017

Performance

As reported in the abstract

Median age

65 years

IQR 49–79

eGFR <60 mL/min/1.73 m 2

20.6%

Diagnosis of AMI

6.4%

Further findings

Relationship between eGFR and troponin in patients without AMI

Inverse log-linear relationship between eGFR and troponin

Diagnostic performance for AMI by eGFR

eGFR>90, C-statistic (best)
0.93
eGFR<15, C-statistic (worst)
0.81

False positive rate of high-sensitive troponin T at conventional cut-off of 14 ng/L, eGFR 15–60 mL/min/1.73 m 2

False positive rates
68-93%

eGFR-specific cut-offs restricting false positive rate to 15%

eGFR 45-60: cut-off
73 ng/L
eGFR 45-60: detection rate
73%
eGFR 30-45: cut-off
112 ng/L
eGFR 30-45: detection rate
70%
eGFR 15-30: cut-off
184 ng/L
eGFR 15-30: detection rate
68%

Original publication

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment. Heart. Published 9 June 2026. doi:10.1136/heartjnl-2025-327658

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.